Silverarc Capital Management as of March 31, 2026
Portfolio Holdings for Silverarc Capital Management
Silverarc Capital Management holds 73 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spdr Series Trust Put Put Option | 10.8 | $105M | 825k | 127.73 | |
| Kalvista Pharmaceuticals | 5.9 | $58M | 2.9M | 20.13 | |
| Dianthus Therapeutics (DNTH) | 5.6 | $55M | 655k | 83.92 | |
| Cogent Biosciences (COGT) | 5.2 | $51M | 1.3M | 38.49 | |
| Celcuity (CELC) | 4.2 | $41M | 358k | 114.14 | |
| Immunome (IMNM) | 4.1 | $41M | 1.9M | 21.87 | |
| Kodiak Sciences (KOD) | 3.9 | $38M | 992k | 38.12 | |
| Nuvalent Inc-a (NUVL) | 3.7 | $36M | 355k | 102.45 | |
| Abivax Sa Sponsored Ads (ABVX) | 3.4 | $34M | 303k | 111.35 | |
| Monte Rosa Therapeutics (GLUE) | 3.4 | $33M | 2.0M | 16.45 | |
| Erasca (ERAS) | 3.1 | $30M | 1.9M | 16.18 | |
| Ascendis Pharma A/s Sponsored Adr | 2.9 | $29M | 125k | 228.73 | |
| Urogen Pharma (URGN) | 2.8 | $27M | 1.5M | 17.98 | |
| Rhythm Pharmaceuticals (RYTM) | 2.7 | $27M | 306k | 86.97 | |
| Praxis Precision Medicines I Com New (PRAX) | 2.4 | $23M | 72k | 322.19 | |
| Zenas Biopharma (ZBIO) | 2.3 | $22M | 1.1M | 19.55 | |
| Syndax Pharmaceuticals (SNDX) | 2.1 | $21M | 889k | 23.36 | |
| Centessa Pharmaceuticals Sponsored Ads | 1.9 | $19M | 466k | 39.72 | |
| Scholar Rock Hldg Corp (SRRK) | 1.7 | $17M | 340k | 49.16 | |
| Alkermes SHS (ALKS) | 1.7 | $16M | 460k | 35.36 | |
| Oric Pharmaceuticals (ORIC) | 1.4 | $14M | 1.1M | 12.67 | |
| Disc Medicine (IRON) | 1.3 | $13M | 196k | 63.94 | |
| Helix Acquisition Corp Iii Usd Cl A Ord Shs (HLXC) | 1.3 | $12M | 1.2M | 10.16 | |
| Xenon Pharmaceuticals (XENE) | 1.2 | $12M | 198k | 58.15 | |
| Cg Oncology (CGON) | 1.1 | $11M | 166k | 67.68 | |
| Immunovant (IMVT) | 1.1 | $10M | 414k | 24.84 | |
| Spyre Therapeutics Com New (SYRE) | 1.0 | $9.4M | 187k | 50.44 | |
| Biogen Idec (BIIB) | 1.0 | $9.3M | 51k | 183.33 | |
| Guardant Health (GH) | 0.9 | $9.1M | 99k | 92.37 | |
| Vaxcyte (PCVX) | 0.9 | $8.4M | 145k | 58.11 | |
| Uniqure Nv Call Call Option | 0.8 | $8.2M | 500k | 16.35 | |
| Savara (SVRA) | 0.8 | $7.8M | 1.4M | 5.46 | |
| Benitec Biopharma Com New (BNTC) | 0.8 | $7.6M | 718k | 10.65 | |
| Syndax Pharmaceuticals Call Call Option | 0.8 | $7.5M | 320k | 23.36 | |
| Oruka Therapeutics (ORKA) | 0.8 | $7.4M | 151k | 49.05 | |
| Compugen Ord (CGEN) | 0.7 | $7.1M | 3.3M | 2.13 | |
| Celcuity Call Call Option | 0.6 | $6.2M | 55k | 114.14 | |
| Trevi Therapeutics (TRVI) | 0.6 | $6.1M | 511k | 11.93 | |
| Insmed Com Par $.01 (INSM) | 0.6 | $5.9M | 36k | 163.52 | |
| Veracyte (VCYT) | 0.6 | $5.8M | 180k | 32.21 | |
| Cerus Corporation (CERS) | 0.6 | $5.8M | 3.2M | 1.82 | |
| Celldex Therapeutics Com New (CLDX) | 0.6 | $5.7M | 178k | 31.72 | |
| C4 Therapeutics Com Stk (CCCC) | 0.5 | $5.0M | 1.9M | 2.63 | |
| Cytokinetics Com New (CYTK) | 0.5 | $4.7M | 71k | 65.91 | |
| Eliem Therapeutics (CLYM) | 0.5 | $4.7M | 685k | 6.85 | |
| Compass Therapeutics (CMPX) | 0.5 | $4.5M | 859k | 5.29 | |
| Surrozen Com New (SRZN) | 0.4 | $4.2M | 144k | 29.13 | |
| Contineum Therapeutics Cl A (CTNM) | 0.4 | $3.9M | 302k | 13.06 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.3 | $3.3M | 561k | 5.95 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $3.2M | 420k | 7.67 | |
| Fulcrum Therapeutics Call Call Option | 0.3 | $3.0M | 392k | 7.67 | |
| Abeona Therapeutics Com New (ABEO) | 0.3 | $2.9M | 649k | 4.48 | |
| Camp4 Therapeutics Corp (CAMP) | 0.3 | $2.9M | 654k | 4.41 | |
| Annexon (ANNX) | 0.3 | $2.8M | 497k | 5.54 | |
| Elutia Cl A Com (ELUT) | 0.3 | $2.6M | 2.5M | 1.05 | |
| Crescent Biopharma (CBIO) | 0.2 | $2.4M | 131k | 18.37 | |
| Monopar Therapeutics Com New (MNPR) | 0.2 | $2.4M | 44k | 54.79 | |
| Ovid Therapeutics (OVID) | 0.2 | $2.2M | 1.0M | 2.22 | |
| Nextcure Com New (NXTC) | 0.2 | $1.9M | 176k | 10.68 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $1.7M | 300k | 5.53 | |
| Neumora Therapeutics (NMRA) | 0.2 | $1.6M | 818k | 1.95 | |
| Sionna Therapeutics (SION) | 0.2 | $1.6M | 39k | 40.09 | |
| Tela Bio (TELA) | 0.1 | $1.4M | 2.3M | 0.62 | |
| Edgewise Therapeutics (EWTX) | 0.1 | $1.3M | 43k | 31.50 | |
| Replimune Group (REPL) | 0.1 | $1.3M | 172k | 7.65 | |
| Generate Biomedicines Com Shs (GENB) | 0.1 | $1.3M | 100k | 12.50 | |
| Compass Therapeutics Call Call Option | 0.1 | $912k | 172k | 5.29 | |
| Radiopharm Theranostics Sponsored Ads (RADX) | 0.1 | $806k | 187k | 4.30 | |
| Fractyl Health (GUTS) | 0.1 | $779k | 1.7M | 0.46 | |
| Ibio Com New (IBIO) | 0.0 | $429k | 226k | 1.90 | |
| Adagio Med Hldgs (ADGM) | 0.0 | $290k | 252k | 1.15 | |
| Aardvark Therapeutics (AARD) | 0.0 | $127k | 34k | 3.77 | |
| Rocket Pharmaceuticals *w Exp 09/02/202 (RCKTW) | 0.0 | $2.2k | 105k | 0.02 |